EQT Private Equity /
QIAGEN
EQT Private Equity agrees to take QIAGEN private at €46.50 per share
- Enterprise value
- €10.8bn
- Stage
- Agreement signed
What happened
QIAGEN N.V. and the EQT XI fund have agreed on an all-cash voluntary public takeover offer for all outstanding QIAGEN shares at €46.50 per share, a premium of 40.3% to the unaffected XETRA closing price of €33.15 on 8 July 2026. The transaction values QIAGEN at approximately €10.8 billion in enterprise value (approximately $12.1 billion, including approximately $1.1 billion of net debt). Co-investors are ADIA's Luxinva and CPP Investments.
QIAGEN's Supervisory Board and Managing Board unanimously recommend acceptance. Closing is expected in mid-2027, subject to a 50% plus one share minimum acceptance threshold and regulatory clearances. Jonathan M. Pratt is Chief Executive Officer of QIAGEN.
The source
Everything on this page comes from the source below.
EQT Private Equity agrees to take QIAGEN private at €46.50 per share
This document is the source for the companies, stage, figure and people on this page.
Original filingUnlock with ProTimeline
Every date the source states, in order. Anything marked ahead is a target the source gives, not something that has happened.
Agreement signed
The source this page is built from.
Published by the source
The source this page is built from.
Expected close
The source this page is built from.
The same firms, in other deals
The firms' deal history and connections across other deals.
These firms' full profiles are part of Pro.
Request accessAlready invited? Sign in
Carrywatch Pro is by invitation. An invite lets you buy Pro.
By email · Weekly